Palisade Bio Inc. (PALI) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts PALI Hot Sheet
Join SI Premium – FREE
Palisade Bio Inc. (NASDAQ: PALI) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $500 thousand.
For earnings history and earnings-related data on Palisade Bio Inc. (PALI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluent (FLNT) Tops Q2 EPS by 4c
- Syntec Optics (OPTX) Tops Q2 EPS by 1c
- Septerna, Inc. (SEPN) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
